ES2059801T3 - Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. - Google Patents

Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.

Info

Publication number
ES2059801T3
ES2059801T3 ES89402632T ES89402632T ES2059801T3 ES 2059801 T3 ES2059801 T3 ES 2059801T3 ES 89402632 T ES89402632 T ES 89402632T ES 89402632 T ES89402632 T ES 89402632T ES 2059801 T3 ES2059801 T3 ES 2059801T3
Authority
ES
Spain
Prior art keywords
lymphocines
new
pharmaceutical compositions
compositions containing
dna sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89402632T
Other languages
English (en)
Inventor
Thierry Hercend
Frederic Triebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2059801T3 publication Critical patent/ES2059801T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TIENE POR OBJETO LINFOQUINAS CONSTITUIDAS POR O QUE CONTIENEN LA SECUENCIA PEPTIDICA RLS PEEYYD LARAH LRDEE KSCPC LAQEG PQGOL LTKTQ ELGRO YRTCL TIVQK LKKMV DKPIQ RSVSN AATRV CRIGR SRWRD VCRNF MRRYQ SRVIQ GLVAG ETAQQ ICEOL RLCIP SIGPL. LA INVENCION IGUALMENTE TIENE POR OBJETO ADN QUE CODIFICA PARA ESTOS POLIPEPTIDOS.
ES89402632T 1988-09-26 1989-09-26 Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. Expired - Lifetime ES2059801T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8812538A FR2636953B1 (fr) 1988-09-26 1988-09-26 Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques

Publications (1)

Publication Number Publication Date
ES2059801T3 true ES2059801T3 (es) 1994-11-16

Family

ID=9370380

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89402632T Expired - Lifetime ES2059801T3 (es) 1988-09-26 1989-09-26 Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.

Country Status (8)

Country Link
EP (1) EP0367641B1 (es)
JP (1) JP2960453B2 (es)
AT (1) ATE111920T1 (es)
DE (1) DE68918399T2 (es)
DK (1) DK130290D0 (es)
ES (1) ES2059801T3 (es)
FR (1) FR2636953B1 (es)
WO (1) WO1990003394A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006195A1 (en) * 1990-09-28 1992-04-16 University Of Minnesota Dna and amino acid sequence specific for natural killer cells and t cells
AU5923398A (en) 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
UA122479C2 (uk) 2014-01-24 2020-11-25 Дана-Фарбер Кенсер Інстітьют, Інк. Виділена молекула антитіла, яка зв’язується з людським білком програмованої смерті-1 (pd-1)
EA201691765A1 (ru) 2014-03-14 2016-12-30 Новартис Аг Молекулы антител против lag-3 и их применения
US20180340025A1 (en) 2015-07-29 2018-11-29 Novartis Ag Combination therapies comprising antibody molecules to lag-3
CN108495651A (zh) 2015-12-17 2018-09-04 诺华股份有限公司 抗pd-1的抗体分子及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260880A3 (en) * 1986-09-11 1990-03-07 Dana-Farber Cancer Institute, Inc. Turning on of cytotoxicity
US4994369A (en) * 1987-12-15 1991-02-19 The Board Of Trustees Of The Leland Stanford Jr. Univ. T-cell activation related gene

Also Published As

Publication number Publication date
AU4405689A (en) 1990-04-18
DE68918399D1 (de) 1994-10-27
DK130290A (da) 1990-05-25
EP0367641A3 (en) 1990-08-29
AU638682B2 (en) 1993-07-08
FR2636953B1 (fr) 1990-12-14
DE68918399T2 (de) 1995-03-16
FR2636953A1 (fr) 1990-03-30
JPH03502697A (ja) 1991-06-20
EP0367641B1 (fr) 1994-09-21
WO1990003394A2 (fr) 1990-04-05
WO1990003394A3 (fr) 1990-07-12
ATE111920T1 (de) 1994-10-15
EP0367641A2 (fr) 1990-05-09
DK130290D0 (da) 1990-05-25
JP2960453B2 (ja) 1999-10-06

Similar Documents

Publication Publication Date Title
MX9203598A (es) Polipeptido novedoso y secuencias de adn que codifican para la sintesis de eritropoyetina.
ES2193145T3 (es) Proteinas procoagulants quimericas.
DK0409472T3 (da) Knoglemorfogenetisk protein
DK0392300T3 (da) Anvendelse af lægemidler, der indeholder mindst et cytokin, til systemisk behandling af præneoplastiske læsioner
DE69518751D1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
FI875220A7 (fi) Mikrobeja tuhoavia proteiineja, niitä sisältäviä koostumuksia ja niiden käyttö.
DE59309207D1 (de) Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DE69528061D1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
ATE388165T1 (de) Menschliches cnp-gen und vorläuferprotein
DE68929430D1 (de) Fibronektin bindendes Protein
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
FI841288A0 (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
FI896261A7 (fi) Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
FI972170A7 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
IL95863A0 (en) Anticoagulant peptides and compositions containing them
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
NO921219D0 (no) Somatostatin reseptor
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
ATE75255T1 (de) Peptid und dafuer kodierendes gen.
ATE101194T1 (de) Azeotropaehnliche zusammensetzungen von 1,3dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367641

Country of ref document: ES